Cairo – Mubasher: Kahira Pharmaceuticals’ net profit before tax declined in March by 6.6% year-on-year to EGP4.2 million from EGP4.5 million, which is EGP0.8 million below estimates, said the company in a bourse filing.
In March as well, the pharmaceutical firm registered a gross sale of EGP41.9 million, compared to EGP39.9 million for the year-ago month, the company added.
During July-January 2015/16, the company’s net profit before tax stood at EGP38.1 million, compared to EGP35 million a year earlier.
On last Sunday, the stock stood at EGP18.05 at close.
